Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Clinical trial NCT02560610 · COMPLETED
Trial details
- NCT number
- NCT02560610
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-08-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.